Cellular therapy in neuromyelitis optica spectrum disorder

Area of Science:

• Neuroimmunology
• Regenerative Medicine
• Cellular Therapeutics

Background:

• Neuromyelitis optica spectrum disorder (NMOSD) is a severe neuroinflammatory disease causing progressive disability.
• Current immunosuppressive treatments for NMOSD manage relapses but do not offer a cure.
• Significant psychological distress and economic burdens are associated with NMOSD.

Purpose of the Study:

• To review recent advancements in cellular therapy for NMOSD.
• To enhance understanding of cellular therapy's role in NMOSD.
• To provide a future research roadmap for NMOSD cellular therapies.

Main Methods:

• Literature review of current research on cellular therapy for NMOSD.
• Synthesis of findings on adult stem cell transplantation.
• Analysis of genetically engineered somatic cell strategies.

Main Results:

• Cellular therapy demonstrates potential for immune modulation and system reorganization in NMOSD.
• Stem cell and engineered somatic cell therapies show promise in preclinical and early clinical studies.
• Advancements focus on improving efficacy and safety profiles for NMOSD treatment.

Conclusions:

• Cellular therapy represents a novel and potentially curative strategy for NMOSD.
• Further research is needed to optimize cellular therapy protocols for NMOSD.
• This review provides a framework for future investigations into NMOSD cellular treatments.